Arcus Biosciences Overview
Arcus Biosciences Target Price
Analysts' 12-month price predictions for RCUS.
Share Price
$8.47
Average Target Price
$26.00
207% upside
207% upside1 analysts in the last 4 months
High: $26 | Low: $26
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-05-07 | Wells FargoEva Fortea Verdejo | $26 | 207% upside |  |
| 2024-10-24 | CitigroupYigal Nochomovitz | $46 | 443.1% upside | |
| 2024-10-21 | H.C. WainwrightEmily Bodnar | $20 | 136.1% upside | |
| 2024-10-08 | Morgan StanleyJudah Frommer | $35 | 313.2% upside | |
| 2024-10-08 | Wells FargoEva Fortea Verdejo | $29 | 242.4% upside | |
| 2024-08-09 | Bank of America SecuritiesJason Zemansky | $23 | 171.5% upside | |
| 2024-07-08 | BarclaysPeter Lawson | $25 | 195.2% upside | |
| 2024-06-24 | Truist FinancialAsthika Goonewardene | $44 | 419.5% upside | |
| 2024-06-04 | BarclaysPeter Lawson | $35 | 313.2% upside | |
| 2022-12-20 | Citigroup | $42 | 395.9% upside | |
| 2022-11-23 | Citigroup | $37 | 336.8% upside | |
| 2022-05-11 | WedbushRobert Driscoll | $42 | 395.9% upside | |